Kaya Holdings (KAYS) Non-Current Assets (2011 - 2025)
Kaya Holdings (KAYS) recorded quarterly Non-Current Assets of $87668.0 in Q3 2025, down 50.06% quarter-over-quarter from $175553.0 in Q2 2025, and down 50.47% on a YoY basis from $177006.0 in Q3 2024.
Kaya Holdings (KAYS) Non-Current Assets (2011 - 2025) Analysis & Trends
Kaya Holdings' Non-Current Assets history runs 15 years deep, the most recent figure standing at $87668.0 for Q3 2025.
- In Q3 2025, Non-Current Assets fell 50.47% year-over-year to $87668.0; the TTM figure through Sep 2025 stood at $87668.0 (down 50.47% YoY), while the FY2024 annual figure was $148431.0, up 24.84% from the prior year.
- Non-Current Assets was $87668.0 for Q3 2025 at Kaya Holdings, down from $175553.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $2.2 million in Q1 2021 to a low of $87668.0 in Q3 2025.
- Historically, Non-Current Assets has averaged $651466.6 across 5 years, with a median of $213484.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Non-Current Assets slumped 87.93% in 2023, then soared 99.33% in 2024.
- A 5-year view of Non-Current Assets shows it stood at $937683.0 in 2021, then declined by 16.31% to $784763.0 in 2022, then tumbled by 84.85% to $118901.0 in 2023, then rose by 24.84% to $148431.0 in 2024, then plunged by 40.94% to $87668.0 in 2025.
- The last three Non-Current Assets figures came in at $87668.0 (Q3 2025), $175553.0 (Q2 2025), and $117466.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.40 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.22 Bn |
| 10 | Kaya Holdings | - | - | 5,370.00 | 87,668.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 87,668.00 |
| Jun 30, 2025 | 175,553.00 |
| Mar 31, 2025 | 117,466.00 |
| Dec 31, 2024 | 148,431.00 |
| Sep 30, 2024 | 177,006.00 |
| Jun 30, 2024 | 213,484.00 |
| Mar 31, 2024 | 94,429.00 |
| Dec 31, 2023 | 118,901.00 |
| Sep 30, 2023 | 107,265.00 |
| Jun 30, 2023 | 107,100.00 |
| Mar 31, 2023 | 240,353.00 |
| Dec 31, 2022 | 784,763.00 |
| Sep 30, 2022 | 878,433.00 |
| Jun 30, 2022 | 887,275.00 |
| Mar 31, 2022 | 909,340.00 |
| Dec 31, 2021 | 937,683.00 |
| Sep 30, 2021 | 2.09 Mn |
| Jun 30, 2021 | 2.15 Mn |
| Mar 31, 2021 | 2.15 Mn |
| Dec 31, 2020 | 2.20 Mn |